Advanced search×

[Neurosarcoidosis--different manifestations].

Ugeskr Laeger 172(48):3344-5 (2010) PMID 21118667

We present six cases with different manifestations of neurosarcoidosis. There are no specific diagnostic tests for sarcoidosis. In the presented cases the diagnosis was made by histological proof of noncaseating granulomas. Patients with systemic sarcoidosis and neurological symptoms should be tested for neurosarcoidosis. All patients with suspected neurosarcoidosis should undergo PET imaging for localizing inflammatory foci of a systemic disease.

Version: za2963e q8za0 q8zbf q8zc2 q8zdf q8ze8 q8zfe q8zg0

Similar articles you may find interesting…

  1. Long-Term Follow-Up on Affinity Maturation and Memory B-Cell Generation in Patients with Common Variable Immunodeficiency.

    J Clin Immunol (2013) PMID 23649616

    Switched memory B cells and levels of SHM were not consistently stable markers in a long-term follow-up setting. At a given time during follow-up, 60 % of the patients were assigned to the EUROclass group SmB- (less than 2 % switched memory B cells), but only 23 % were consistently assigned to th...
  2. Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients.

    Mol Biol Rep (2013) PMID 23645091

    The immunological role of interleukin 27 has been reported in various inflammatory diseases, but its importance in systemic lupus erythematosus pathogenesis is not completely established. The aim of this study was to evaluate serum levels of IL-27 in SLE patients and its correlation...
  3. Catalase has a key role in protecting cells from the genotoxic effects of monomethylarsonous acid: A highly active metabolite of arsenic.

    Environ Mol Mutagen (2013) PMID 23640787

    Although it is widely known that arsenic-contaminated drinking water causes many diseases, arsenic's exact mode of action (MOA) is not fully understood. Induction of oxidative stress has been proposed as an important key event in the toxic MOA of arsenic. The authors' studies are cen...